NCT00323505
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Royal Marsden NHS trust Sutton, Surrey, United Kingdom
Clinical trial condition
Immunoproliferative Disorders
Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.
9,958 public trials
2,018 recruiting studies
Immunoproliferative Disorders trial results
NCT00306969
- Conditions
- Cutaneous T-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
- Locations
-
- Boston University Medical Center Boston, Massachusetts, United States
NCT00305149
- Conditions
- Classical Hodgkin Lymphoma, Hemic and Lymphatic Diseases, Hodgkin Disease, +11 more
- Locations
-
- Eldad Dann Haifa, Israel
NCT00301275
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Royal Marsden NHS trust Sutton, Surrey, United Kingdom
NCT00054808
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +15 more
- Locations
-
- Genta Berkeley Heights, New Jersey, United States
NCT00045864
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
- Locations
-
- ACRC/Arizona Clinical Research Center, Inc. Tucson, Arizona, United States
- Hoag Cancer Center Newport Beach, California, United States
- UC Davis Cancer Center Sacramento, California, United States
- John Wayne Cancer Institute Santa Monica, California, United States
NCT00045877
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
- Comprehensive Blood and Cancer Center Bakersfield, California, United States
- California Oncology of the Central Valley Fresno, California, United States
- Virginia K. Crosson Cancer Center Fullerton, California, United States
Completed
Study of Intravenous BCX-1777 in Relapsed or Refractory Aggressive T-Cell Leukemias or Lymphomas
NCT00035022
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- M.D. Anderson Cancer Center Houston, Texas, United States
NCT00262210
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- National Taiwan University Hospital Taipei, Taiwan
NCT00078065
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Oncotherapeutics Los Angeles, California, United States
- University of California, San Diego San Diego, California, United States
- University of California, San Francisco San Francisco, California, United States
- Johns Hopkins Medical Institute Baltimore, Maryland, United States